Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Now Available in e-book Format: Author Benjamin Vance’s Debut Science Fiction Novel, ‘Adamonde’ Investigates the Darker Side of Human Nature
  • USA - English


News provided by

Nov 27, 2013, 07:00 ET

Share this article

Share toX

Share this article

Share toX

'Adamonde' by Benjamin Vance
'Adamonde' by Benjamin Vance

Phoenix, Arizona (PRWEB) November 27, 2013 -- Now available in e-book format; Benjamin Vance’s ‘Adamonde’ unveils a female extraterrestrial that is transported to Earth from one of only three inhabited planets in the universe. She’s been granted cosmic knowledge to assist in saving Earth from its slide into extinction and upon her arrival is rescued physically and mentally by a young man who is attempting suicide. Together they somehow find mutual healing and eventually deep love.

People should read ['Adamonde'] if they believe in the innate goodness of life, love and family, wherever its origin, and whenever it’s found.

Post this

The mature storyline revolves around unselfish sentiments, enduring love, antagonist murder and treachery. A large Swiss pharmaceutical company hires assassins and repeatedly attempts to capture or kill Adamonde to attain her unique biological properties for selfish gain. Adamonde and her group receive assistance from the Mormon Church, the government of a small Caribbean country, the World Health Organization and from many dissimilar humans in their quest to simply be left alone to enjoy each other, raise their hybrid children and teach Earth how to extend life and reduce suffering among its inhabitants.

In their frantic search for peace they stumble across a developing race of alien hybrids on earth that have been living and propagating a furtive and comfortable life, thanks to another of Adamonde's kind who traveled to Earth over a hundred years earlier. The two aliens quickly become friends and their extended families combine to combat various groups of killers hired by the pharmaceutical company and others.

Vance develops the cast and dialog to demonstrate the immense barriers that exist during attempts to present enriching scientific facts to Earth’s population; expecting even a small fraction to understand or care about the redeeming effects. The characters repeatedly attempt to convince the world that Adamonde is real and has life-giving information for Earth, but are not taken seriously; even reviled. Various politicians, the world’s largest Christian religion and U.S. media require obdurate proof of her powers and even after those powers are demonstrated in earnest; are neither appreciated nor understood.

In order to validate Adamonde fully, the characters turn to an International Science Fiction Conference venue and illicitly demonstrate her powers there. Although accepted by hundreds in the convention, a wider audience seems impossible until the small Caribbean country allows Adamonde to speak in her native language to the United Nations General Assembly. Although given immense credibility after her speech, she is also exposed to the very foes who want to consume her for their own remuneration.

Appealing not only to Science Fiction enthusiasts, Vance interweaves several love stories in order to give the novel a more humanistic fielding. Adamonde, her husband Jonathan and their friends Nic and Jessana become involved in a loving and protective extended family that contributes to Adamonde’s wellbeing and safety. The various attributes of the family somewhat align with Waardenberg Syndrome and serendipitously provide a believable and cleverly deceptive façade for the group.

The family is finally forced to meet the antagonists head-on in a battle that leaves many dead and their vengeful blood lust hopefully sated. The final battle amalgamates the family into a formidable opponent and finally ensures their place in free society.

"Adamonde highlights the drastic lengths to which many powerful and influential people and groups will go to control events, information and to retain power," says Vance.

"People should read this book if they believe in the innate goodness of life, love and family, wherever its origin, and whenever it’s found."

"Adamonde" is published exclusively in ebook format by eBookIt.com and is available from popular online retailers, including Amazon.com, BN.com, and Apple’s iBookstore.

Contact
William W. Southworth
Benvance.book(at)gmail(dot)com
Telephone: 928-821-1469

About Benjamin Vance

Benjamin Vance is a retired Military Officer and Veterinarian. His two degrees in business have buttressed two successful businesses, as well as Vance being awarded two patents and nine copyrights. Having lived in Germany, The Philippines, Vietnam and several U.S. States, Vance now makes his home in the Southwest.

About eBookIt.com

Since 2010, eBookIt.com (based in Sudbury, Massachusetts) has helped thousands of authors and publishers get their books converted to ebook format, and distributed to all the major ebook retailers, including Amazon.com, Barnesandnoble.com, Apple iBookstore, Kobo, Sony Readerstore, Ingram Digital, and Google eBookstore.

William W. Southworth, http://www.benjaminvancebooks.com, +1 928-821-1469, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.